While the scRNA-seq data focused on gene expression changes in sAH compared to HC, using flow cytometry, we were able to expand our study to look at heavy drinkers, moderate AH, and NASH. Here, ACSM3 is linked to metabolic dysfunction-associated steatohepatitis.